Contact
Please use this form to send email to PR contact of this press release:
NASDAQ Company Announces 1st Patient Dosing for Placebo Controlled Trial of JW-300 Jupiter Wellness Inc. (NASDAQ: JUPW)
TO:
JUPW
Jupiter Wellness, Inc
561-244-7100